Skip to content

Comparing the effectiveness of Individualized Homeopathic medicine and placebo in the Treatment for Dyslipidemia: BOTH GROUPS ARE ON STATINS

Assessing the efficacy of individualized homoeopathic medicine in the treatment of dyslipidemia randomized placebo-controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087880
Enrollment
108
Registered
2025-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

Intervention1: Individualized homoeopathic medicine: Individualized homoeopathic medicine Appropriate potency based on the Susceptibility analysis Follow up of the subjects will be done once in 3 mont

Sponsors

Dr Swetha B P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are willing to participate as volunteer in the study with written informed consent. Subjects aged 25 to 65 years both genders Subjects with at least one of the following factors: cholesterol level more than 200 mg/dl or TG level higher than 150-239 mg/dl or LDL C level higher than 130-160mg/dL or HDL C level less than 40 mg/dl , less than 40 mg/dl for women and less than 35 mg/dl for men.) Smoking Hypertension on antihypertensive medications

Exclusion criteria

Exclusion criteria: The patients who had a history of chronic or metabolic diseases such as diabetes, ischemic heart disease, hypertension, tachycardia, peripheral vascular disease, coronary artery disease, thyroid dysfunction, hospitalized, cannot follow therapeutic lifestyle modification. Pregnant and lactating mothers. History of coronary artery disease at an early age in the household (less than 55 years in males and in females under age 65 years old)

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of individualized homoeopathic medicine as an adjuvant in the management of Dyslipidemia with lifestyle modificationTimepoint: 6 months

Secondary

MeasureTime frame
To study the efficacy constitutional similimum on lowering or tapering of anti-hyperlipidemic medicines doses among dyslipidemia patients span of 6 months. To enlist commonest homoeopathy remedies having therapeutic effect in treating dyslipidemia in span of 6 months.Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Sujata R Kamire

Maharashtra University of Health Science (MUHS)

sujatakamire@yahoo.com09823195866

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026